ID: ALA3357622

Max Phase: Preclinical

Molecular Formula: C19H24BrN3O6

Molecular Weight: 470.32

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COc1cccc(COC(=O)N2CCC[C@H]2C(=O)NC[C@@H]2CC(Br)=NO2)c1OC

Standard InChI:  InChI=1S/C19H24BrN3O6/c1-26-15-7-3-5-12(17(15)27-2)11-28-19(25)23-8-4-6-14(23)18(24)21-10-13-9-16(20)22-29-13/h3,5,7,13-14H,4,6,8-11H2,1-2H3,(H,21,24)/t13-,14-/m0/s1

Standard InChI Key:  FQZHHQVIEFGUIH-KBPBESRZSA-N

Associated Targets(Human)

Protein-glutamine gamma-glutamyltransferase K 164 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Protein-glutamine gamma-glutamyltransferase 1221 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 470.32Molecular Weight (Monoisotopic): 469.0848AlogP: 2.42#Rotatable Bonds: 7
Polar Surface Area: 98.69Molecular Species: NEUTRALHBA: 7HBD: 1
#RO5 Violations: 0HBA (Lipinski): 9HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: CX LogP: 1.63CX LogD: 1.63
Aromatic Rings: 1Heavy Atoms: 29QED Weighted: 0.66Np Likeness Score: -0.84

References

1. Klöck C, Herrera Z, Albertelli M, Khosla C..  (2014)  Discovery of potent and specific dihydroisoxazole inhibitors of human transglutaminase 2.,  57  (21): [PMID:25333388] [10.1021/jm501145a]

Source